Nicole J Moreland Selected Research

Rheumatic Fever (Acute Articular Rheumatism)

1/2021	Mapping Autoantibodies in Children With Acute Rheumatic Fever.
1/2021	Antibody responses to collagen peptides and streptococcal collagen-like 1 proteins in acute rheumatic fever patients.
1/2021	Searching for a technology-driven acute rheumatic fever test: the START study protocol.
1/2020	The Limitations of the Rheumatogenic Concept for Group A Streptococcus: Systematic Review and Genetic Analysis.
1/2020	Development and Evaluation of a New Triplex Immunoassay That Detects Group A Streptococcus Antibodies for the Diagnosis of Rheumatic Fever.
1/2020	The Treatment of Acute Rheumatic Fever: Novel Use of Hydroxychloroquine.
1/2019	Streptococcal Serology in Acute Rheumatic Fever Patients: Findings From 2 High-income, High-burden Settings.
1/2018	Group A Streptococcus pharyngitis and pharyngeal carriage: A meta-analysis.
1/2018	The novel Group A Streptococcus antigen SpnA combined with bead-based immunoassay technology improves streptococcal serology for the diagnosis of acute rheumatic fever.
11/2017	Clinical development strategy for a candidate group A streptococcal vaccine.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicole J Moreland Research Topics

Disease

12	Infections 12/2022 - 01/2012
12	Rheumatic Fever (Acute Articular Rheumatism) 01/2021 - 07/2014
8	Pharyngitis (Sore Throat) 12/2022 - 01/2014
7	Dengue (Dengue Fever) 01/2014 - 11/2010
3	COVID-19 12/2022 - 01/2020
2	Leukemia 01/2020 - 01/2018
2	Rheumatic Heart Disease (Rheumatic Heart Diseases) 01/2018 - 11/2017
2	Tuberculosis (Tuberculoses) 06/2008 - 01/2008
1	Disease Progression 01/2021
1	Cross Infection (Nosocomial Infection) 01/2021
1	Convalescence 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Inflammation (Inflammations) 01/2020
1	Streptococcal Infections (Streptococcal Infection) 01/2019
1	Virus Diseases (Viral Diseases) 01/2018
1	Myocarditis (Carditis) 01/2018
1	Impetigo (Impetigo Contagiosa) 11/2017

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2008
10	VaccinesIBA 12/2022 - 01/2012
9	AntibodiesIBA 01/2022 - 01/2012
5	AntigensIBA 12/2022 - 01/2014
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2017
3	deoxyribonuclease BIBA 12/2022 - 01/2019
3	Immunoglobulin G (IgG)IBA 01/2021 - 07/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	EpitopesIBA 01/2021 - 01/2012
2	CytokinesIBA 01/2021 - 01/2020
2	C-Reactive ProteinIBA 01/2021 - 01/2020
2	InterferonsIBA 01/2021 - 01/2018
2	DimethylformamideIBA 01/2020 - 01/2018
2	Monoclonal AntibodiesIBA 01/2020 - 01/2012
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2018
2	Immunoglobulin FragmentsIBA 01/2014 - 01/2014
1	Neutralizing AntibodiesIBA 12/2022
1	CarbohydratesIBA 12/2022
1	small cardioactive peptide AIBA 12/2022
1	Peptides (Polypeptides)IBA 01/2021
1	streptolysin OIBA 01/2021
1	CollagenIBA 01/2021
1	Myosins (Myosin)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	AutoantigensIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2021
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	AntistreptolysinIBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	TransferasesIBA 01/2014
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 01/2014
1	Glycoproteins (Glycoprotein)IBA 01/2012
1	Pharmaceutical PreparationsIBA 10/2011
1	Peptide Hydrolases (Proteases)FDA Link 10/2011
1	factor 420 (F(420))IBA 06/2008
1	ProdrugsIBA 06/2008
1	pretomanidIBA 06/2008
1	Citric Acid (Citrate)FDA LinkGeneric 06/2008
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 06/2008

Therapy/Procedure

1	Therapeutics 06/2008